- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
FGFR1 AntibodyPeptide-affinity purified goat antibody
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AF1411a | 0.1mg 400 ul | 7-10 days | $ 325.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
FGFR1 Antibody - Product info | |
| Other Accession | NP_075599 |
| Reactivity | Human |
| Concentration | 100ug/200ul |
| Isotype | IgG |
FGFR1 Antibody - Additional info | |
| Other Names FGFR1; H2; H3; H4; H5; CEK; FLG; FLT2; KAL2; BFGFR; C-FGR; N-SAM; fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome); FLG protein; N-sam tyrosine kinase; tyrosylprotein kinase; protein-tyrosine kinase; FMS-like tyrosine kinase 2; hydroxyaryl-protein kinase; fms-related tyrosine kinase-2; heparin-binding growth factor receptor; basic fibroblast growth factor receptor 1; fibroblast growth factor receptor 1; CD331; FGFBR; FLJ99988; HBGFR; OGD; OTTHUMP00000190881; soluble FGFR1 variant 1; soluble FGFR1 variant 2 | |
| Format 0.5 mg IgG/ml in Tris saline (20mM Tris pH7.3, 150mM NaCl), 0.02% sodium azide, with 0.5% bovine serum albumin | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions FGFR1 Antibody is for research use only and not for use in diagnostic or therapeutic procedures. | |
FGFR1 Antibody - Application data
-
AF1411a (0.3 µg/ml) staining of human breast lysate (35 µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
-
AF1411a (4 µg/ml) staining of paraffin embedded Human Small Intestine. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.
FGFR1 Antibody - Related products
AP3104a: Phospho-FGFR-pY653/654 Antibody
AP3105a: Phospho-FGFR-Y766 Antibody
AP3105b: Phospho-FGFR1-pY766 Antibody
AP3311a: Phospho-FGFR1-Y307 Antibody
AP3312a: Phospho-FGFR1-Y463 Antibody
AP3313a: Phospho-FGFR1-Y654 Antibody
AP3420a: Phospho-FGFR1-pY154 Antibody
AP3755a: Phospho-FGFR- Y653 Antibody
AP7636b: FGFR1 Antibody (C-term)
AP7636d: FGFR1 Antibody (Y463)
AP7636e: FGFR1 Antibody (Y654)
AP7636f: FGFR1 Antibody (Y766)
AP7636g: FGFR1 Antibody (Y653)
AP7636h: FGFR1 Antibody (Y154)
AP7636i: FGFR1 Antibody (C-term)
RI11993: FGFR1 predesign siRNA
LY10425a: FGFR1 Over-expression Lysate
BP3104a: Phospho-FGFR-Y653/654 Antibody Blocking Peptide
BP3105a: Phospho-FGFR-Y766 Antibody Blocking Peptide
BP3105b: Phospho-FGFR1-pY766 Antibody Blocking Peptide
BP3311a: Phospho-FGFR1-Y307 Antibody Blocking Peptide
BP3312a: Phospho-FGFR1-Y463 Antibody Blocking Peptide
BP3313a: Phospho-FGFR1-Y654 Blocking Peptide
BP3420a: Phospho-FGFR1-pY154 Antibody Blocking Peptide
BP7636a: FGFR1 Antibody (N-term) Blocking Peptide
BP7636b: FGFR1 Antibody (C-term) Blocking Peptide
BP7636d: FGFR1 Antibody (Y463) Blocking Peptide
BP7636e: FGFR1 Antibody (Y654) Blocking Peptide
BP7636f: FGFR1 Antibody (Y766) Blocking Peptide
BP7636g: FGFR1 Antibody (Y653) Blocking Peptide
BP7636h: FGFR1 Antibody (Y154) Blocking Peptide
BP9814a: FGFR1-Y307 Antibody Blocking Peptide
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. Mutations in this gene have been associated with Pfeiffer syndrome, Jackson-Weiss syndrome, Antley-Bixler syndrome, osteoglophonic dysplasia, and autosomal dominant Kallmann syndrome 2. Chromosomal aberrations involving this gene are associated with stem cell myeloproliferative disorder and stem cell leukemia lymphoma syndrome. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized.
REFERENCES
FGF21 signalling pathway and metabolic traits - genetic association analysis. Kaess BM, et al. Eur J Hum Genet, 2010 Aug 18. PMID 20717167. Genetic variants in COL2A1, COL11A2, and IRF6 contribute risk to nonsyndromic cleft palate. Nikopensius T, et al. Birth Defects Res A Clin Mol Teratol, 2010 Jul 29. PMID 20672350. Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia. Jugessur A, et al. PLoS One, 2010 Jul 9. PMID 20634891. Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway. Kamura S, et al. Br J Cancer, 2010 Jul 27. PMID 20606682. Association between genetic variants of reported candidate genes or regions and risk of cleft lip with or without cleft palate in the polish population. Mostowska A, et al. Birth Defects Res A Clin Mol Teratol, 2010 Jul. PMID 20544801.